SFA
APTO

Sequoia Financial Advisors’s Aptose Biosciences, Inc. APTO Stock Holding History

Sequoia Financial Advisors’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-44
Closed -$12.8K – 1007
2023
Q1 		$12.8K Hold
44
– – ﹤0.01% 836
2022
Q4 		$11.6K Hold
44
– – ﹤0.01% 803
2022
Q3 		$12K Hold
44
– – ﹤0.01% 529
2022
Q2 		$15K Hold
44
– – ﹤0.01% 591
2022
Q1 		$27K Buy
+44
New +$24.3K ﹤0.01% 667

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Sequoia Financial Advisors's APTO Position: Q2 2023 in Review

Sequoia Financial Advisors sold out of Aptose Biosciences, Inc. (APTO) in Q2 2023, closing a stake of 44 shares — an estimated $12.8K sold.

Sequoia Financial Advisors first reported a position in APTO in Q1 2022 and held it in 5 quarters. The position peaked at $27K in Q1 2022. 24 funds tracked by Wall St. Rank hold APTO as of Q2 2023.

  • Sequoia Financial Advisors reported no remaining Aptose Biosciences, Inc. position as of Q2 2023 after selling out during the quarter.
  • Sequoia Financial Advisors sold 44 Aptose Biosciences, Inc. shares in Q2 2023, an estimated $12.8K.
  • Sequoia Financial Advisors first reported a position in Aptose Biosciences, Inc. in Q1 2022 and held it in 5 quarters.
  • Sequoia Financial Advisors's Aptose Biosciences, Inc. position peaked at $27K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2023.

Based on Sequoia Financial Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.